NMPA Approval

Disitamab Vedotin For Injection

Approval Number

国药准字S20237006

Registration Date

August 21, 2023

Previous Approval Numbers

国药准字S20210017

Drug Information

Generic Name

注射用维迪西妥单抗

Trade Name

爱地希

Dosage Form

注射剂

Strength

40mg/支

Drug Type

生物制品

Registration Date

August 21, 2023

Company Address

中国（山东）自由贸易试验区烟台片区烟台开发区北京中路58号

Company Address

中国（山东）自由贸易试验区烟台片区烟台开发区北京中路58号

Empowering clinical research with data-driven insights and AI-powered tools.

注射用维迪西妥单抗 - NMPA 批准文号 | MedPath